Cytokine Release Syndrome Results in Reduced AML Killing By CD123 CAR T Cells
Anand Bhagwat(Children's Hospital of Philadelphia), Saar Gill(Parker Institute for Cancer Immunotherapy), Jennifer L. Brogdon, Don L. Siegel(University of Pennsylvania), Carl H. June(University of Pennsylvania), Selina M. Luger(University of Pennsylvania), James K. Mangan(UC San Diego Health System), Edward A. Stadtmauer(University of Pennsylvania), Joseph A. Fraietta(University of Pennsylvania), Alexander E. Perl(University of Pennsylvania), Alison W. Loren(University of Pennsylvania), Maksim Shestov(University of Pennsylvania), Saad S. Kenderian(Mayo Clinic in Arizona), Olga Shestova(University of Pennsylvania), Leonel Torres(University of California, San Francisco), Shannon R. McCurdy(Hospital of the University of Pennsylvania), Noelle V. Frey(Hospital of the University of Pennsylvania), Elizabeth O. Hexner(University of Pennsylvania), Mary Ellen Martin(University of Pennsylvania), David Porter(University of Pennsylvania), Wei‐Ting Hwang(California University of Pennsylvania)
Cited by 5
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k